
Clinical Impact of Compensatory Hyperinflation of the Nontreated Adjacent Lobe After Bronchoscopic Lung Volume Reduction with Valves
Author(s) -
Johannes Wienker,
Kaid Darwiche,
Julia Wälscher,
J Winantea,
Michael Hagemann,
E Büscher,
Abhinav Singla,
Christian Taube,
Rüdiger Karpf-Wissel
Publication year - 2022
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s364448
Subject(s) - medicine , lung volume reduction , hyperinflation , lung volumes , lung , reduction (mathematics) , pneumonectomy , bronchoscopy , lung volume reduction surgery , cardiology , radiology , surgery , monetary policy , geometry , mathematics , monetary economics , economics
Bronchoscopic lung volume reduction (BLVR) with endobronchial valves (EBV) can be a successful treatment for end-stage emphysema patients. The reduction of hyperinflation enhances ventilatory mechanics and diaphragm function. Understanding predictors for treatment success is crucial for further improvements.